期刊文献+

壳聚糖的纳米化及其生物学效应 被引量:3

Biological effect of chitosan nanoparticles
下载PDF
导出
摘要 目的:综合分析壳聚糖纳米微粒的制备方法、研究进展及其生物学效应资料来源:应用计算机检索PUBMED 1998-01/2006-12有关壳聚糖纳米化方面的文献,检索词“Chitosan;nanoparticles”,同时计算机检索超星数字图书库2000-01/2006-12期间的相关文献,检索词为“壳聚糖”。资料选择:对资料进行初审,并查看每篇文献后的引文。选择针对性强的文章。同一领域的选择近期或权威杂志的文章。资料提炼:共收集到259篇相关文献,其中34篇符合纳入标准,排除25篇。符合纳入标准的34篇文献中,26篇涉及壳聚糖纳米粒的制备,8篇涉及纳米化后产生的生物学效应。资料综合:壳聚糖作为一类带正电的多糖,其性质不活泼,不与体液和体内组织产生免疫反应,并具有很好的生物相容性和生物可降解性。目前壳聚糖纳米化主要采用离子交联法、沉淀法、共价交联法、乳化溶剂扩散挥发法、自组装法等方法。纳米化后具有增加药物的吸收作用、增加药物的靶向性和降低药物副作用、增强药物的缓释作用及提高药物稳定性的生物学效应。结论:壳聚糖纳米粒的研究已成为当前生物医学领域的热点。纳米化后的壳聚糖在缓控释给药系统中具有广阔的应用前途,但其溶解性能有待于进一步提高。 OBJECTIVE: To comprehensively analyze the preparation method, study progress and biological effect of chitosan nanoparticles. DATA SOURCES: A computer-based online search of PUBMED was undertaken for articles about the chitosan nanoparticles published from January 1998 to December 2006, with the key words of "chitosan; nanoparticles". Meanwhile, Chaoxing database was searched for related articles published from January 2000 to December 2006 with the key word of "chitosan". STUDY SELECTION: After the primary check, the quotation of each literature was looked up. The data were arranged to select the articles with strong points. As to the same field, the articles published recently or in authoritative magazines were preferred. DATA EXTRACTION: Totally 259 relevant literatures were collected and 34 articles met the requirements, while 25 articles were excluded. Of the inclusive 34 literatures, 26 were about the preparation of chitosan nanoparticles and 8 were about the biological effect of chitosan nanoparticles. DATA SYNTHESIS: Chitosan is a cationic polysaccharide, which is inactive, doesn't make immune responses with the body fluid and in vitro organization, with good biocompatibility and biodegradability. At present, the preparation methods of chitosan nanoparticles are ionic cross-linking, deposition, cross-linked with glutaraldehyde, emulsification solvent diffusion, chitosan self-aggregation and so on. The chitosan nanoparticles can increase the drug absorption, target characteristic, release behavior, and the stabilization characteristic, additionally decrease the drug side effect. CONCLUSION: Recently, the chitosan nanoparticles have been widely investigated in the biomedical fields, reveals as a promising system for the controlled release of drug delivery systems, but the capability of dissolution characteristic needs further study.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2007年第26期5190-5193,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 浙江省科技厅重大项目资助(2005F11010)~~
  • 相关文献

参考文献33

  • 1Muzzarelli R.Biochemical significance of exogenous chitins.and chitosans in animals and patients.Carbohyd Polym 1993;20:7-i6
  • 2Tang ZX,Qian JQ,Shi LE.Preparation of chitosan nanoparticles as carrier for immobilized enzyme.Appl Biochem Biotechnol 2007;136(1):77-96
  • 3Bravo-Osuna I,Vauthier C,Farabollini A,et al.Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles.Biomaterials 2007;28(13):2233-2243
  • 4Bravo-Osuna I,Ponchel G,Vauthier C.Tuning of shell and core characteristics of chitosan-decorated acrylic nanoparticles.Eur J Pharm Sci 2007;30(2):143-154
  • 5Mansouri S,Cuie Y,Winnik F,et al.Characterization of folate-chitosan-DNA nanoparticles for gene therapy.Biomaterials 2006;27(9):2060-2065
  • 6Guliyeva U,Oner F,Ozsoy S,et al.Chitosan microparticles containing plasmid DNA as potential oral gene delivery system.Eur J Pharm Biopharm 2006;62(1):17-25
  • 7Berthold A,Cromer K.Kreuter J.Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs odel for anti-inflammatory drug.J Control Release 1996;39(1):17-25
  • 8Tian XX,Groves MJ.Formulation and biological activity of antineoplastic proteoglycans derived from Mycobacterium vaccae in chitosan nanoparticles.J Pharm Pharmacol 1999;51(2):151-157
  • 9Banerjee T,Mitra S,Kumar Singh A,et al.Preparation,characterization and biodistribution of ultrafine chitosan nanoparticles.Int J Pharm 2002;243(1-2):93-105
  • 10Peniche H,Osorio A,Acosta N,et al.Preparation and characterization of superparamagnetic chitosan microspheres:Application as a support for the immobilization of tyrosinase.J Appl Polym Sci 2005;98:651-657

二级参考文献17

  • 1[1]Carreno-Gomez B,Duncan R.Evaluation of t he biological properties of soluble chitosan and chitosan microspheres[J].In t J Pharm,1997,148(2):231.
  • 2[2]de C ampos AM,Sanchez A,Alonso MJ.Chitosan nanoparticles:a new vehicle for the improvement of the delivery of drugs to the ocular surface.Application to cyclosporin A[J].Int J Pharm,2001,224 (1-2 ):159.
  • 3[3]Illum L,Jabbal Gill I,Hinchcliffe M.Chito san as a novel nasal delivery system for vaccines[J].Adv Drug Deliv Rev,20 01,51(1-3):81.
  • 4[4]Artursson P,Lindmark T,Davis SS,et al .Effect of chitosan on the permeability of monolayers of intestinal epithelial c ells (Caco-2)[J].Pharm Res,1994,11(9):1358.
  • 5[5]Schipper NGM,Varum KM,Stenberg P,et al .Chitosan as absorption enhancers for poorly absorbable drugs 3:Influence of m ucus on absorption enhancement[J].Eur J Pharm Sci,1999,8(4):335.
  • 6[6]Rainer HM,Karsten M,Sven G.Solid lipid na noparticles(SLN) for controlled drug delivery-a review of the state of the art [J].Eur J Pharm Biopharm,2000,50(1):161.
  • 7Douglas SJ, Davis SS, Illum L. Nanoparticles in drug delivery. Crit Rev Ther Drug Carrier Syst, 1987,3(3): 233
  • 8Lamprecht A,Rodero Torres H,Schafer U, et al.Biodegradable microparticles as a two-drug controlled release formulation:a potential treatment of inflammatory bowel disease.J Controlled Release,2000,69(3):445
  • 9Sabnis S, Block LH. Chitosan as an enabling excipient for drug delivery systems.Biol Int J Biol Macromol,2000,27(3):181
  • 10李玉宝 顾宁 魏于全.纳米生物医药材料[M].北京:化学工业出版社,2003.121.

共引文献17

同被引文献58

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部